The event occurred in (b)(6) and was initially determined as not reportable to the competent authorities in the region.However, as part of an internal review, the event has been re-assessed as a reportable event in finland and subsequently reported to their competent authorities.Therefore, this initial and final emdr is being submitted to fda for this as a reportable event that occurred outside the usa.Injector malfunction is indicated as a potential malfunction related to the injector system, as covered under the warnings section of the product's instructions for use (ifu).The product was not returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.Trend analysis was conducted.This complaint rate is within established threshold value and the customer does not require an investigation report.Exact root cause was not determined.However, based on available information, we believe the event is not related to our product quality.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.
|
Reportedly, a split cartridge / tip occurred.According to the reporter, there was an increase incision that required sutures to be closed.The lens remained into the patient's eye after clinical assessment.Patient condition and symptoms: no clinical signs, symptoms or conditions.
|